These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 18684881)

  • 1. Mast cells and mastocytosis.
    Metcalfe DD
    Blood; 2008 Aug; 112(4):946-56. PubMed ID: 18684881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of normal and neoplastic human mast cell development in mastocytosis.
    Metcalfe DD
    Trans Am Clin Climatol Assoc; 2005; 116():185-203; discussion 203-4. PubMed ID: 16555614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
    Rottem M; Okada T; Goff JP; Metcalfe DD
    Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.
    Jackson CW; Pratt CM; Rupprecht CP; Pattanaik D; Krishnaswamy G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting c-kit in the therapy of mast cell disorders: current update.
    El-Agamy DS
    Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.
    Chan EC; Bai Y; Kirshenbaum AS; Fischer ER; Simakova O; Bandara G; Scott LM; Wisch LB; Cantave D; Carter MC; Lewis JC; Noel P; Maric I; Gilfillan AM; Metcalfe DD; Wilson TM
    J Allergy Clin Immunol; 2014 Jul; 134(1):178-87. PubMed ID: 24582309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and Pathology of Mastocytosis.
    Metcalfe DD; Mekori YA
    Annu Rev Pathol; 2017 Jan; 12():487-514. PubMed ID: 28135563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis.
    Robyn J; Metcalfe DD
    Adv Immunol; 2006; 89():169-243. PubMed ID: 16682275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
    Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
    J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells and inflammation.
    Frenzel L; Hermine O
    Joint Bone Spine; 2013 Mar; 80(2):141-5. PubMed ID: 23116710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase network regulating mast cell activation.
    Gilfillan AM; Rivera J
    Immunol Rev; 2009 Mar; 228(1):149-69. PubMed ID: 19290926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stinging Hymenoptera and mastocytosis.
    Ruëff F; Dugas-Breit S; Przybilla B
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases.
    Shenker BJ; Ali H; Boesze-Battaglia K
    Curr Pharm Des; 2011 Nov; 17(34):3815-22. PubMed ID: 22103853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction and chemotaxis in mast cells.
    Draber P; Halova I; Polakovicova I; Kawakami T
    Eur J Pharmacol; 2016 May; 778():11-23. PubMed ID: 25941081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells signal their importance in health and disease.
    Olivera A; Beaven MA; Metcalfe DD
    J Allergy Clin Immunol; 2018 Aug; 142(2):381-393. PubMed ID: 29454835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.
    Saleh R; Wedeh G; Herrmann H; Bibi S; Cerny-Reiterer S; Sadovnik I; Blatt K; Hadzijusufovic E; Jeanningros S; Blanc C; Legarff-Tavernier M; Chapiro E; Nguyen-Khac F; Subra F; Bonnemye P; Dubreuil P; Desplat V; Merle-Béral H; Willmann M; Rülicke T; Valent P; Arock M
    Blood; 2014 Jul; 124(1):111-20. PubMed ID: 24677542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.
    Furumoto Y; Charles N; Olivera A; Leung WH; Dillahunt S; Sargent JL; Tinsley K; Odom S; Scott E; Wilson TM; Ghoreschi K; Kneilling M; Chen M; Lee DM; Bolland S; Rivera J
    Blood; 2011 Nov; 118(20):5466-75. PubMed ID: 21926349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIN3 is a negative regulator of mast cell responses to SCF.
    Janson C; Kasahara N; Prendergast GC; Colicelli J
    PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.